NITRIC-OXIDE PROTECTS AGAINST ALKYL PEROXIDE-MEDIATED CYTOTOXICITY - FURTHER INSIGHTS INTO THE ROLE NITRIC-OXIDE PLAYS IN OXIDATIVE STRESS

被引:112
作者
WINK, DA
COOK, JA
KRISHNA, MC
HANBAUER, I
DEGRAFF, W
GAMSON, J
MITCHELL, JB
机构
[1] NCI, FREDERICK CANC RES & DEV CTR, COMPARAT CARCINOGENESIS LAB, CHEM SECT, FREDERICK, MD 21702 USA
[2] NCI, RADIAT BIOL BRANCH, TUMOR BIOL SECT, BETHESDA, MD 20892 USA
[3] NHLBI, CHEM PHARMACOL LAB, BETHESDA, MD 20892 USA
关键词
OXIDATIVE STRESS; NITRIC OXIDE; LIPID PEROXIDATION; PROTECTION; ANTIOXIDANT;
D O I
10.1006/abbi.1995.1310
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endogenously formed nitric oxide (NO) possesses diverse properties such as regulating physiological functions, exerting specific toxic effects, and protecting against various toxic substances. Recent studies suggest that in the presence of reactive oxygen species, NO can serve as an antioxidant. We show here that NO delivered from the NO donor compound, PAPA/NO (NH2(C3H6) (N[N(O)NO](C3H7)), protects Chinese hamster V79 lung fibroblasts from the cytotoxicity of t-butyl hydroperoxide and cumene hydroperoxide. In contrast, the other end products of PAPA/NO degradation in aqueous solution, NH2(C3H6)NH(C3H7) and nitrite, did not protect. The NONOate DEA/NO releases NO six times faster than PAPA/NO, yet did not afford protection, which implies that NO must be present throughout the alkyl hydroperoxide exposure. Measurements of NO concentrations released from PAPA/NO suggest that micromolar levels protect against cytotoxicity induced by alkyl hydroperoxides. These findings demonstrate that the flux of NO sustained over the duration of the peroxide exposure determines protection and not the total of NO delivered. These results suggest that concentrations of NO produced in the microenvironment of endothelial cells are high enough to protect cells from Fenton-type-mediated toxicity and support the premise that NO may exert a salutary effect in certain diseases associated with membrane damage. (C) 1995 Academic Press, Inc.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 42 条
[1]  
Moncada S., Palmer R.M.J., Higgs E.A., Pharmacol. Rev, 43, pp. 109-142, (1991)
[2]  
Hogg N., Darley-Usmar V.M., Wilson M.T., Moncada S., FEBS Lett, 326, pp. 199-203, (1993)
[3]  
Beckman J.S., Smith C.M., Koppenol W.H., Nature, 364, (1993)
[4]  
Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H., Proc. Natl. Acad. Sci, USA, 88, pp. 6368-6371, (1991)
[5]  
Johnson G., Phillip S., Tsao B.S., Lefer A.M., Crit. Care Med, 19, pp. 244-252, (1991)
[6]  
Masini E., Bianchi S., Mugnai L., Gambassi F., Lupini M., Pistelli A., Mannaioni P.F., Agents Actions, 33, pp. 53-56, (1991)
[7]  
Morikawa E., Huang Z., Moskowitz M.A., Am. J. Physiol, 263, pp. H1632-H1635, (1992)
[8]  
Linz W., Wiemer G., Scholkens B.A., J. Mol. Cell Cardiol, 24, pp. 909-919, (1992)
[9]  
Siegfried M.R., Erhardt J., Rider T., Ma X.L., Lefer A.M., J. Pharmacol. Exp. Ther., 260, pp. 668-675, (1992)
[10]  
Yates M.T., Lambert L.E., Whitten J.P., McDonald I., Mano M., Ku G., Mao S.J.T., FEBS Lett, 309, pp. 135-138, (1992)